Abstract: Go, one of the most abundant heterotrimeric G proteins in the brain, is classified as a member of the Gi/Go family based on its homology to Gi proteins. Recently, we identified promyelocytic leukemia zinc finger protein (PLZF) as a candidate downstream effector for the alpha subunit of Go (Gαo).
INTRODUCTION
Heterotrimeric GTP-binding proteins (G proteins) mediate signal transduction and amplification in a variety of cell-signaling pathways [1] [2] [3] . In its inactive state, the alpha subunit (Gα) of the heterotrimeric G protein contains a bound GDP and has a high affinity for the Gβγ heterodimeric subunit. When activated by an appropriate signal, membrane-bound G protein-coupled receptors bind the heterotrimer, forming a quaternary complex that catalyzes the exchange of the bound GDP for GTP in Gα. This exchange facilitates the sequential dissociation of Gα from the Gβγ dimer, and the release of these G protein subunits from the receptor. The dissociated Gα and/or Gβγ participate(s) in interactions with various downstream effectors. Go, one of the most abundant G proteins expressed in the brain [4] , is classified as a member of the Gi/Go family by virtue of its sequence homology to Gi proteins. However, unlike the α-subunits of Gi proteins, which inhibit adenylyl cyclase and decrease intracellular cyclic AMP levels, the α-subunit of Go (Gαο) has no effect on adenylyl cyclase; its role, other than to act as a reservoir of βγ subunits available for liberation upon receptor activation, is unclear at present. Recently, we identified PLZF as a Gαο-interacting partner [5] . Activated Gαο interacts directly with PLZF and enhances its cellular function as a repressor of transcription and cell growth. These findings indicate that Gαο can modulate cell growth-related gene expression via PLZF activation. PLZF was initially identified as a fusion protein with the retinoid acid receptor resulting from a variant t(11;17) chromosomal translocation that occurs in a small subset of acute promyelocytic leukemia patients [6] . The PLZF protein, which is highly conserved among humans, mice, and chickens [7] , is a nuclear protein that has at its C-terminus nine C 2 -H 2 zinc finger motifs that bind directly to DNA [8] . The amino terminus of PLZF contains a BTB/POZ domain that mediates self-dimerization and transcriptional repression by binding to nuclear co-repressors, such as N-CoR, SMRT, Sin3A, and histone deacetylases [9] [10] [11] . PLZF functions as a transcriptional regulator of cell-cycle progression by binding to the promoter of target genes, such as those for cyclin A and the interleukin-3 receptor α chain [12] [13] [14] [15] . Analysis of PLZF knock-out mice revealed that the protein is a growth inhibitor and pro-apoptotic factor in the limb bud in vivo [16] . PLZF is also involved in the differentiation of cells, including megakaryocytes [17] , osteoblasts [18] , and neurons [19] . In this study, we confirmed a direct interaction between Gαο and PLZF and characterized the functional domain of Gαο in modulating the function of PLZF.
MATERIALS AND METHODS

Plasmids
The plasmids pGEX2T-Gαο and pGEX2T-PLZF were respectively used to express the glutathione-S-transferase (GST) fusion proteins of Gαο and PLZF [5] .
The plasmids pRC/CMV-Gαο and pRC/CMV-Gαο Q205L were respectively used to express the wild-type and activated mutant forms (Gαο Q205L ) of Gαο [20] . The plasmids pcFLAG-PLZF and pcHA-PLZF were respectively used to express FLAG-and HA-tagged PLZF [5] .
Co-immunoprecipitation
GST, GST-Gαο, and GST-PLZF fusion proteins were purified according to a standard protocol [21] . Purified proteins (5 μg each) were mixed in PBTX buffer (PBS containing 5 mM MgCl 2 , 1 mM EDTA, 1% Triton X-100 and protease inhibitors) containing 0.1% BSA, as indicated. The protein mixtures were pre-cleared by incubation with 20 μl of Protein A-Sepharose CL-4B beads (10% slurry; Amersham Bioscience) and then incubated with 1 μg of the indicated antibody with gentle rotation for 4 h at 37ºC, followed by incubation with 50 μl beads. After a 2-h room-temperature incubation, the beads were washed with PBTX buffer. The bound proteins were eluted with an SDS sample buffer, separated by SDS-PAGE and immunoblotted with antibodies against PLZF (1:100 dilution, Calbiochem) or Gαο (1:500 dilution, Santa Cruz Biotechnology).
Construction of the Gαο deletion mutants
Gαο deletion mutant expression plasmids (pGEX2T-GαοΔN, pGEX2T-GαοΔNH, pGEX2T-GαοΔG, and pGEX2T-GαοΔHL2G) encoding the GSTtagged version of the Gαο deletion mutants (respectively, GST-GαοΔN, GST-GαοΔNH, GST-GαοΔG, and GST-GαοΔHL2G) were constructed as follows. Gαο cDNA was amplified by PCR from a pRC/CMV-Gαο template using the following primers: for GαοΔN, 5'-CCA TGA TGA TGG CTT CTC T-3' and 5'-TCA GTA CAA GCC ACA GCC-3'; for GαοΔNH, 5'-CAA AAC AAC TGG CAT CGT A-3' and 5'-TCA GTA CAA GCC ACA GCC-3'; for GαοΔG, 5'-GGA ATT CGA TTC ATG GGA-3 and 5'-TAC GAT GCC AGT TGT TTT-3'; and for GαοΔHL2G, 5'-GGA ATT CGA TTC ATG GGA-3' and 5'-AGA GAA GCC ATC TTC ATG-3'. The amplified products were inserted into pGEX2T (Amersham Bioscience). The pGEX2T-GαοΔL2 deletion mutant plasmid was generated by the BamHI digestion and self-ligation of pGEX2T-Gαο. Expression plasmids (pcFLAG-GαοΔL2G) encoding FLAG-tagged versions of the Gαο deletion mutants (FLAG-GαοΔL2G) were created by the BamHI digestion and self-ligation of pcFLAG-Gαο.
GST pull-down assay
Bacterial cell lysates containing GST fusion proteins were incubated with glutathione-Sepharose 4B beads (Amersham Bioscience) for 1 h at 4ºC in PBTX buffer, and then washed extensively with PBXT. 293T cell extracts (500 μg) expressing the FLAG-PLZF protein were added to the beads and incubated for 1 h at 37ºC. After extensive washing with PBTX buffer, the bound proteins were eluted with SDS sample buffer and subjected to immunoblot analysis using antibodies against FLAG (1:500 dilution, Sigma).
BrdU-incorporation assay
293T cells were plated on coverslips at a density of 1x10 3 per coverslip and transfected with combinations of expression plasmids, as indicated in the text. The GFP expression plasmid, pEGFP (Clontech), was employed as a transfection marker under all conditions. After incubation for 24 to 48 h to allow expression by the transfected plasmids, the cells were labeled with 10 μM bromodeoxyuridine (BrdU) and incubated for 12 h, then washed with PBS and fixed in 4% paraformaldehyde for 15 min. After fixation, 2 N HCl was applied for 30 min followed by 0.1 M sodium borate (pH 8.5) for 10 min. The cells were subsequently incubated with antibodies against BrdU (1:250 dilution, Sigma) and GFP (1:500 dilution, Molecular Probe) at 4ºC overnight. Their immunoreactivity was visualized using Alexa Fluor 568-conjugated goat antimouse IgG and Alexa Fluor 488-conjugated goat anti-rabbit IgG (Molecular Probe). To visualize the nuclei, the cells were counterstained with DAPI (Vector Laboratories).
Luciferase reporter gene assay 293T cells were plated on 6-well tissue culture dishes at a density of 5x10 5 cells per well and transfected with the indicated expression plasmids and CyclinA2-Luc reporter gene plasmid [22] . To normalize the transfection efficiency, the cells were transfected with 0.3 μg of a β-galactosidase (β-gal) expression plasmid (pCMV-β-gal). A constant total amount of plasmid DNA was maintained in the transfections by adding pcDNA3 (Invitrogen). After 24 h, the 293T cells were serum starved for 16 h and harvested. Cell lysates were assayed for luciferase and β-gal activity using a Luciferase assay system (Promega), as recommended by the manufacturer.
Cyclin A expression 293T cells (1.5x10 6 cells/dish) were plated on 100-mm tissue culture dishes. The cells were transfected with appropriate combinations of expression plasmids, as indicated in the text, then lysed with RIPA buffer (50 mM Tris-Cl, pH.7.5, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS and protease inhibitors). Extracts were subjected to immunoblot analysis using antibodies against cyclin A (1:500 dilution, Santa Cruz Biotechnology) or α-tubulin (1:1000 dilution, Upstate Biotechnology).
RESULTS AND DISCUSSION
Gαο interacts directly with PLZF
In our previous study, we identified PLZF as a Gαο-interacting protein and showed that Gαο binds directly to PLZF and promotes its cellular functions [5] . To confirm that these proteins directly interact, we purified the GST fusion proteins of Gαο and PLZF from bacterial lysates for use in co-immunoprecipitation assays. As shown in Fig. 1 , after the indicated incubation, the purified proteins were co-immunoprecipitated, showing that Gαο interacts with PLZF without the assistance of other proteins. Fig. 1 . Direct interaction between Gαο and PLZF. Purified GST, GST-Gαο and GST-PLZF were incubated and subjected to a co-immunoprecipitation assay, as described in the Materials and Methods section. The input indicates lanes loaded with the 10% purified protein mixtures used for immunoprecipitation.
The GTPase domain of Gαο contributes to PLZF interaction
G proteins consist of at least three domains: an N-terminal domain; an α-helical domain unique to the highly homologous family of heterotrimeric G-proteins; and a GTPase domain common to members of the GTPase superfamily. These domains are interconnected by two linker sequences (L1 and L2). To identify the regions of Gαο that bind to PLZF, we constructed a series of deletion mutants and expressed them as GST fusion proteins with the GST epitope at the N-termini ( Fig. 2A) . GST pull-down assays were performed by incubating purified GST-tagged deletion mutants with 293T cell extracts containing exogenously expressed FLAG-PLZF and examining for PLZF retention by Gαο mutant proteins. Deleting the N-terminus (GST-GαοΔN) alone or together with the helical domain (GST-GαοΔNH) did not affect Gαο interactions with PLZF (Fig. 2B, lanes 3 and 4) . The mutant lacking the L2 domain (GST-GαοΔL2) likewise retained the ability to interact with PLZF (Fig. 2B, lane 7) . Importantly, deleting the GTPase domain alone (GST-GαοΔG) or together with the helical domain (GST-GαοΔHL2G) abolished PLZF binding (Fig. 2B, lanes 5 and 6) . These results indicate that the specific determinant of Gαo:PLZF interaction resides in the C-terminal half of Gαο (residues 213 to 354). This region includes only amino acids that contribute to the formation of the GTPase domain of Gαο, and excludes the helical domain. We previously found that Gαο interacts directly through its GTPase domain with cAMP-dependent protein kinase (PKA), thereby compartmentalizing PKA signaling [21] . Thus, the GTPase domain of Gαο may be necessary for its interaction with related proteins. B -Beads charged with bacterially expressed GST fusion proteins were incubated with 293T cell extracts expressing 10 μg of the FLAG-PLZF plasmid. Bound proteins were immunoblotted with anti-FLAG antibodies. The input indicates lanes loaded with the 10% 293T cell extracts used in the GST pull-down assays. Coomassie blue staining was used to show GST fusion protein levels.
The Gαο GTPase domain-deletion mutant does not modulate PLZF activity
Gαο activation augments PLZF's function as a cell growth suppressor and transcriptional repressor [5] . To establish the effects of the Gαο GTPase deletion mutant on cell growth regulation by PLZF, we performed BrdU incorporation assays on 293T cells co-expressing Gαο Q205L or FLAG-GαοΔL2G, a mutant lacking residues 137 to 354 of Gαο, together with HA-PLZF. The GFP expression plasmid, pEGFP, was employed as a transfection marker under all conditions. Co-expression of PLZF and Gαο Q205L reduced the percentage of BrdU-positive S-phase cells among the GFP-positive cells (Fig. 3A and B) . Importantly, this marked repression was completely abolished by co-expression of GαοΔL2G and PLZF. Next, to determine the effects of the Gαο GTPase deletion mutant on the transcriptional repressor function of PLZF, we evaluated the expression of cyclin A2, a target gene of PLZF, employing a luciferase reporter gene assay. Co-expression of PLZF and Gαο Q205L decreased cyclin A2 3 μg) , as indicated. Cell extracts were subsequently assayed for luciferase reporter activity. The data is presented as the average ± S.E. of at least three independent experiments. *p < 0.05, compared to control. **p < 0.01. B -Extracts of 293T cells transfected with expression plasmids for Gαο Q205L (3 μg), FLAG-GαοΔL2G (3 μg), and HA-PLZF (20 μg) were subjected to immunoblot analysis using an antibodies against cyclin A. α-tubulin was used as an internal control.
gene expression compared with the control level (Fig. 4A) . Co-expression of PLZF and GαοΔL2G did not alter cyclin A2 promoter-dependent expression compared with PLZF alone. Changes in the cyclin A protein expression levels were consistent with the data obtained from luciferase reporter assays (Fig. 4B) . These results collectively suggest that the GTPase domain of Gαο serves a functional role as a regulator of PLZF activity. The GTPase domain of G proteins plays a pivotal role in the functional interaction between G protein and several other proteins, including PKA, tubulin, and adenylyl cyclase. The GTPase domain of Gαο specifically interacts with PKA and contributes to its subcellular localization [21] . The part of the GTPase domain (α2−β4 and α3−β5 domain) in Gαs protein contributes to interaction with tubulin, the building block of microtubules, and their interaction modulates microtubule polymerization [23] . The analysis of the crystal structure of adenylyl cyclase and Gαs reveal that the GTPase domain of Gαs plays an important role in the functional interaction [24] . In this study, the Gαο GTPase domain contributes to the specific interaction with PLZF and modulates its functions. Therefore, the GTPase domain of G proteins is an important region in signal transduction of heterotrimeric G proteins. It was recently reported that PLZF expression is downregulated in some cancers, and there is evidence to suggest that PLZF may act as a tumor suppressor [25, 26] . Ectopic expression of PLZF in several cell lines induced growth arrest and apoptosis [27] [28] [29] . In our previous study, activation of the Gi/Go-coupled cannabinoid receptor significantly increased PLZF-mediated cell growth arrest in the human acute promyelocytic leukemia cell line, HL60. Thus, if these functional properties of PLZF and the signaling pathways for PLZF activation are supported by additional in vitro and in vivo experiments, it may be possible to utilize PLZF as a molecular target in cancer management. Gαο is the most abundant heterotrimeric G protein expressed in the brain; its expression in neuroblastoma cell lines, including PC12, N1E-115, Neuro2a, and F11 cells, is sufficient to promote neuritogenesis [30] [31] [32] . In addition, as noted above, PLZF has been shown to induce cell differentiation in a neuronal cell line [19] . It is thus tempting to speculate that GTPase domain-mediated interactions of Gαο with PLZF play an important role in neuronal differentiation. In this study, we confirmed a direct interaction between Gαο and PLZF, and determined that the GTPase domain of Gαο contributes to its functional interaction with PLZF. Collectively, these findings suggest that upon activation, Gαο acts via its GTPase domain to promote the function of PLZF.
